Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Luteolytic Agents
CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo.
Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremia.
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Treatment of hairy cell leukemia with recombinant alpha 2 interferon.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment of hairy cell leukemia with recombinant alpha 2 interferon.
Treatment of hairy cell leukemia with recombinant alpha 2 interferon. Blood. 1985 Mar; 65(3):644-8.
View in:
PubMed
subject areas
Adult
Female
Humans
Interferon Type I
Leukemia, Hairy Cell
Lymphopenia
Male
Middle Aged
Monocytes
Thrombocytopenia
authors with profiles
James W. Vardiman
Mark Ratain